Phase 1 Trials In a first-in-human, randomized, placebo-controlled, single ascending dose, phase 1 trial in healthy participants, retatrutide demonstrated a favourable safety profile (similar to other incretin-based therapies) and early signs of efficacy with dose-dependent WL [42]
smoking), the environment (e
Research use only means BPC-157 is sold exclusively for in-vitro laboratory and scientific study not a drug or supplement, not FDA-approved for clinical use, and must not be consumed by humans or animals
Consult with our specialists to determine if this treatment is right for you and start your journey to better health today.
Does the peptide amount change when I add water
Made in the USA and third-party tested for quality and purity you can trust